Zealand Pharma A/S
OTC:ZLDPF

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
OTC:ZLDPF
Watchlist
Price: 64.82 USD -1.96% Market Closed
Market Cap: 4.6B USD
Have any thoughts about
Zealand Pharma A/S?
Write Note

Wall Street
Price Targets

ZLDPF Price Targets Summary
Zealand Pharma A/S

Wall Street analysts forecast ZLDPF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZLDPF is 144.53 USD with a low forecast of 110.77 USD and a high forecast of 176.57 USD.

Lowest
Price Target
110.77 USD
71% Upside
Average
Price Target
144.53 USD
123% Upside
Highest
Price Target
176.57 USD
172% Upside
Zealand Pharma A/S Competitors:
Price Targets
IMNM
Immunome Inc
227% Upside
AZT
Arcticzymes Technologies ASA
14% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
4% Downside
300122
Chongqing Zhifei Biological Products Co Ltd
53% Upside
ELDN
Eledon Pharmaceuticals Inc
255% Upside
ORY
Oryzon Genomics SA
187% Upside
214450
PharmaResearch Co Ltd
6% Downside
SYRE
Spyre Therapeutics Inc
344% Upside

Revenue
Forecast

Revenue Estimate
Zealand Pharma A/S

For the last 8 years the compound annual growth rate for Zealand Pharma A/S's revenue is -15%. The projected CAGR for the next 3 years is 205%.

-15%
Past Growth
205%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-33%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZLDPF's stock price target?
Price Target
144.53 USD

According to Wall Street analysts, the average 1-year price target for ZLDPF is 144.53 USD with a low forecast of 110.77 USD and a high forecast of 176.57 USD.

What is Zealand Pharma A/S's Revenue forecast?
Projected CAGR
205%

For the last 8 years the compound annual growth rate for Zealand Pharma A/S's revenue is -15%. The projected CAGR for the next 3 years is 205%.

Back to Top